{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-038669","form_type":"8-K","ticker":"PURE","cik":"0001006028","company_name":"PURE BIOSCIENCE, INC.","filed_at":"2023-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.817772+00:00","generated_at":"2026-06-09T05:29:14.825079+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"PURE Bioscience reports FY2023 net loss of $4.0M, revenue up slightly; Q4 revenue jumps 49% YoY","bullets":["Net product sales $1.871M vs $1.813M prior year (+3.2%); net loss widened to $4.0M from $3.5M.","Cash used in operations increased to $3.3M from $2.5M; net loss per share unchanged at ($0.04).","Q4 revenue increased 49% YoY; CEO sees turning point and confirms new customer-driven programs.","Company moving to all-remote work model, closing Rancho Cucamonga facility to reduce costs.","Introduced 'PURE GENIUS' food safety solution at IAFP conference; now in multiple food processing facilities."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-038669","json":"https://secwatch.observer/filing/0001493152-23-038669.json","markdown":"https://secwatch.observer/filing/0001493152-23-038669.md","text":"https://secwatch.observer/filing/0001493152-23-038669.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006028/000149315223038669/0001493152-23-038669-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006028/000149315223038669/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T05:29:14.825079+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5e7aaac2754ae7a5c775efa5bcf37e563e4dba68","claim":"PURE BIOSCIENCE, INC. reported financial results for fiscal year ended July 31, 2023.","evidence_excerpt":"On October 30, 2023, PURE Bioscience, Inc. (the “Company”) issued a press release announcing financial results for the fiscal year ended July 30, 2023 and related information.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315223038669/0001493152-23-038669-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year ended July 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}